{"database": "lobbying", "table": "lobbying_activities", "rows": [[3044714, "b915aaef-b8fc-42dc-bebf-12f93c1b2adf", "Q3", "WATKINS & EAGER PLLC", 401104403, "ZYNERBA PHARMACEUTICALS, INC.", 2023, "third_quarter", "PHA", "Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2023-10-04T11:16:34-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3044714"], "units": {}, "query_ms": 51.569834002293646, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}